ConvaTec Group PLC (OTCMKTS:CNVVY – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totaling 2,799 shares, a growth of 515.2% from the April 30th total of 455 shares. Based on an average daily volume of 48,205 shares, the short-interest ratio is currently 0.1 days.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein raised ConvaTec Group to a “strong-buy” rating in a research note on Wednesday, January 28th. Two investment analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, ConvaTec Group presently has a consensus rating of “Strong Buy”.
View Our Latest Analysis on ConvaTec Group
ConvaTec Group Trading Down 2.1%
ConvaTec Group Company Profile
ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.
Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.
See Also
- Five stocks we like better than ConvaTec Group
- If the Market Rally Stalls, This ETF Can Insulate Portfolios
- Semtech’s Explosive Rally May Only Be Getting Started
- Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
- The Food Delivery War Just Entered Its Final Phase
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
